DrugsControl Media Services

News Detail

CDSCO says samples labelled as Cipla's and Sun Pharma's drugs failed in July could be spurious (25-09-2023)

New Delhi, 25 Sept 2023: The Central Drugs Standard Control Organisation (CDSCO) has declared the samples of Cipla's benign prostatic hyperplasia drug Urimax D it tested in July as spurious drug, and is investigating on Sun Pharma Laboratories' tip off that its bad cholesterol lo......
View Details

Source : Pharmabiz
CDSCO Cipla prostatic hyperplasia drug Urimax D spurious drug Sun Pharma cholesterol Rosuvas 10 Not of Standard Quality NSQ Mankind Pharma Intas Pharmaceuticals KAPL tamsulosin hydrochloride dutasteride Urimax D Drugs and Cosmetics Act antidiabetic Glimestar M2 Forte Mankind Pharma Amtas PRP Adani Wilmar

Related News